Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit

ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

(2012) O.A. Cornely et al.   CLINICAL MICROBIOLOGY AND INFECTION

Clinical Performance of the (1,3)-β-d-Glucan Assay in Early Diagnosis of Nosocomial Candida Bloodstream Infections

(2011) Valerio Del Bono et al.   Clinical and Vaccine Immunology

Reactivity of (1 → 3)-β-d-glucan assay in bacterial bloodstream infections

(2011) O. Albert et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Diagnostic Accuracy of Serum 1,3-β-d-Glucan for Pneumocystis jiroveci Pneumonia, Invasive Candidiasis, and Invasive Aspergillosis: Systematic Review and Meta-Analysis

(2011) Akira Onishi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Does ampicillin-sulbactam cause false positivity of (1,3)-beta-D-glucan assay? A prospective evaluation of 15 patients without invasive fungal infections*

(2011) Gokhan Metan et al.   MYCOSES

Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008)

(2011) Anna Maria Tortorano et al.   MYCOSES

Epidemiology, Species Distribution, Antifungal Susceptibility and Outcome of Nosocomial Candidemia in a Tertiary Care Hospital in Italy

(2011) Matteo Bassetti et al.   PLoS One

Can bacteraemia lead to false positive results in 1,3-beta-d-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections

(2011) Gökhan Metan et al.   REVISTA IBEROAMERICANA DE MICOLOGIA

Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study*

(2010) Daniel H. Kett et al.   CRITICAL CARE MEDICINE

Epidemiology of invasive candidiasis

(2010) Maiken C Arendrup   Current Opinion in Critical Care

The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-d-glucan in patients without risk factors for invasive fungal infections

(2010) G. Metan et al.   INFECTION

Difficulties in using 1,3- -D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies - high frequency of false-positive results and their analysis

(2010) Z. Racil et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease

(2009) Sophia Koo et al.   CLINICAL INFECTIOUS DISEASES

The Role of the Laboratory in the Diagnosis of Invasive Candidiasis

(2009) Maria Teresa Montagna et al.   DRUGS

Epidemiology, Incidence and Risk Factors for Invasive Candidiasis in High-Risk Patients

(2009) Ercole Concia et al.   DRUGS

International Study of the Prevalence and Outcomes of Infection in Intensive Care Units

(2009) Jean-Louis Vincent   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Current diagnostic approaches to invasive candidiasis in critical care settings

(2009) Javier Pemán et al.   MYCOSES

Pseudomonas aeruginosaas a Cause of 1,3‐β‐d‐Glucan Assay Reactivity

(2008) Monique A. S. H. Mennink‐Kersten et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Assessment of the clinical utility of serial  -D-glucan concentrations in patients with persistent neutropenic fever

(2008) M. Ellis et al.   JOURNAL OF MEDICAL MICROBIOLOGY